These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 17499868)
1. Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients. Nordsmark M; Eriksen JG; Gebski V; Alsner J; Horsman MR; Overgaard J Radiother Oncol; 2007 Jun; 83(3):389-97. PubMed ID: 17499868 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels. Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190 [TBL] [Abstract][Full Text] [Related]
3. Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study. Eriksen JG; Overgaard J; Radiother Oncol; 2007 Jun; 83(3):383-8. PubMed ID: 17543403 [TBL] [Abstract][Full Text] [Related]
4. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia inducible factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy. Koukourakis MI; Giatromanolaki A; Danielidis V; Sivridis E Int J Radiat Biol; 2008 Jan; 84(1):47-52. PubMed ID: 17852557 [TBL] [Abstract][Full Text] [Related]
6. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix. Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867 [TBL] [Abstract][Full Text] [Related]
7. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma. Kwon OJ; Park JJ; Ko GH; Seo JH; Jeong BK; Kang KM; Woo SH; Kim JP; Hwa JS; Carey TE Head Neck; 2015 Apr; 37(4):505-10. PubMed ID: 24677746 [TBL] [Abstract][Full Text] [Related]
8. Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial. Overgaard J; Eriksen JG; Nordsmark M; Alsner J; Horsman MR; Lancet Oncol; 2005 Oct; 6(10):757-64. PubMed ID: 16198981 [TBL] [Abstract][Full Text] [Related]
9. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer. Winter SC; Shah KA; Han C; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL Cancer; 2006 Aug; 107(4):757-66. PubMed ID: 16826581 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters. Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515 [TBL] [Abstract][Full Text] [Related]
11. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890 [TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas. Le QT; Kong C; Lavori PW; O'byrne K; Erler JT; Huang X; Chen Y; Cao H; Tibshirani R; Denko N; Giaccia AJ; Koong AC Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):167-75. PubMed ID: 17707270 [TBL] [Abstract][Full Text] [Related]
13. Is the hypoxia-inducible factor pathway important in gastric cancer? Griffiths EA; Pritchard SA; Welch IM; Price PM; West CM Eur J Cancer; 2005 Dec; 41(18):2792-805. PubMed ID: 16290133 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia-related molecules HIF-1α, CA9, and osteopontin : predictors of survival in patients with high-grade glioma. Erpolat OP; Gocun PU; Akmansu M; Ozgun G; Akyol G Strahlenther Onkol; 2013 Feb; 189(2):147-54. PubMed ID: 23263636 [TBL] [Abstract][Full Text] [Related]
15. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. Koukourakis MI; Bentzen SM; Giatromanolaki A; Wilson GD; Daley FM; Saunders MI; Dische S; Sivridis E; Harris AL J Clin Oncol; 2006 Feb; 24(5):727-35. PubMed ID: 16418497 [TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer. Tan EY; Campo L; Han C; Turley H; Pezzella F; Gatter KC; Harris AL; Fox SB Breast Cancer Res; 2007; 9(6):R89. PubMed ID: 18096060 [TBL] [Abstract][Full Text] [Related]
17. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699 [TBL] [Abstract][Full Text] [Related]
18. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Kaanders JH; Wijffels KI; Marres HA; Ljungkvist AS; Pop LA; van den Hoogen FJ; de Wilde PC; Bussink J; Raleigh JA; van der Kogel AJ Cancer Res; 2002 Dec; 62(23):7066-74. PubMed ID: 12460928 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Koukourakis MI; Giatromanolaki A; Sivridis E; Simopoulos K; Pastorek J; Wykoff CC; Gatter KC; Harris AL Clin Cancer Res; 2001 Nov; 7(11):3399-403. PubMed ID: 11705854 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix. Hutchison GJ; Valentine HR; Loncaster JA; Davidson SE; Hunter RD; Roberts SA; Harris AL; Stratford IJ; Price PM; West CM Clin Cancer Res; 2004 Dec; 10(24):8405-12. PubMed ID: 15623619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]